CytomX director John A. Scarlett to retire at June 15, 2022 annual meeting

CytomX Therapeutics, Inc.

John A. Scarlett, M.D. informed CytomX of his retirement from the board, effective at the next annual meeting on June 15, 2022.
Dr. Scarlett's retirement is not the result of any dispute or disagreement with the company.
The retirement is a planned departure at the end of his current term.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John A. Scarlett

Director

CTMX · CytomX Therapeutics, Inc.

Effective: 2022-06-15
Filed: April 14, 2022, 7:59 PM ET

On April 11, 2022, John A. Scarlett, M.D. informed CytomX Therapeutics, Inc. (the “Company”) of his retirement from the Company’s board of directors, effective when his current term expires at the Company’s next annual meeting of stockholders, which is currently scheduled to be held on June 15, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John A. Scarlett retired as Director at CytomX Therapeutics, Inc..

Action: retired
Role: Director

Exact text from the filing

On April 11, 2022, John A. Scarlett, M.D. informed CytomX Therapeutics, Inc. (the “Company”) of his retirement from the Company’s board of directors, effective when his current term expires at the Company’s next annual meeting of stockholders, which is currently scheduled to be held on June 15, 2022.

View on SEC.gov

CytomX Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-105580

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.